Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
G. Fruhbeck, J. Gomez-Ambrosi.
Control of body weight: a physiologic and transgenic perspective.
Diabetologia, 46 (2003), pp. 143-172
[2.]
B.M. Spiegelman, J.S. Flier.
Obesity and the regulation of energy balance.
Cell, 104 (2001), pp. 531-543
[3.]
J.O. Hill, H.R. Wyatt, G.W. Reed, J.C. Peters.
Obesity and the environment: where do we go from here?.
Science, 299 (2003), pp. 853-855
[4.]
S. Kenchaiah, J.C. Evans, D. Levy, P.W. Wilson, E.J. Benjamin, M.G. Larson, et al.
Obesity and the risk of heart failure.
N Engl J Med, 347 (2002), pp. 305-313
[5.]
K.R. Fontaine, D.T. Redden, C. Wang, A.O. Westfall, D.B. Allison.
Years of life lost due to obesity.
JAMA, 289 (2003), pp. 187-193
[6.]
E.E. Calle, C. Rodriguez, K. Walker-Thurmond, M.J. Thun.
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
N Engl J Med, 348 (2003), pp. 1625-1638
[7.]
A. Cheng, N. Uetani, P.D. Simoncic, V.P. Chaubey, A. Lee-Loy, C.J. McGlade, et al.
Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.
Dev Cell, 2 (2002), pp. 497-503
[8.]
G. Fruhbeck, J. Gomez Ambrosi.
Rationale for the existence of additional adipostatic hormones.
FASEB J, 15 (2001), pp. 1996-2006
[9.]
G. Fruhbeck, J. Gomez-Ambrosi, F.J. Muruzabal, M.A. Burrell.
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.
Am J Physiol Endocrinol Metab, 280 (2001), pp. E827-E847
[10.]
V. Wallenius, K. Wallenius, B. Ahren, M. Rudling, H. Carlsten, S.L. Dickson, et al.
Interleukin-6-deficient mice develop matureonset obesity.
Nat Med, 8 (2002), pp. 75-79
[11.]
F. Massiera, M. Bloch-Faure, D. Ceiler, K. Murakami, A. Fukamizu, J.M. Gasc, et al.
Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.
FASEB J, 15 (2001), pp. 2727-2729
[12.]
A. Fortuno, A. Rodriguez, J. Gomez-Ambrosi, P. Muniz, J. Salvador, J. Diez, et al.
Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta.
Endocrinology, 143 (2002), pp. 3555-3560
[13.]
S. Engeli, P. Schling, K. Gorzelniak, M. Boschmann, J. Janke, G. Ailhaud, et al.
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?.
Int J Biochem Cell Biol, 35 (2003), pp. 807-825
[14.]
P.E. Morange, D. Bastelica, M.F. Bonzi, B. Van Hoef, D. Collen, I. Juhan-Vague, et al.
Influence of t-PA and u-PA on adipose tissue development in a murine model of diet-induced obesity.
Thromb Haemost, 87 (2002), pp. 306-310
[15.]
D.E. Cummings, D.S. Weigle, R.S. Frayo, P.A. Breen, M.K. Ma, E.P. Dellinger, et al.
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
N Engl J Med, 346 (2002), pp. 1623-1630
[16.]
M.A. Cowley, R.G. Smith, S. Diano, M. Tschop, N. Pronchuk, K.L. Grove, et al.
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.
Neuron, 37 (2003), pp. 649-661
[17.]
R.L. Batterham, M.A. Cowley, C.J. Small, H. Herzog, M.A. Cohen, C.L. Dakin, et al.
Gut hormone PYY3-36 physiologically inhibits food intake.
Nature, 418 (2002), pp. 650-654
[18.]
K. Miyawaki, Y. Yamada, N. Ban, Y. Ihara, K. Tsukiyama, H. Zhou, et al.
Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Nat Med, 8 (2002), pp. 738-742
[19.]
A. Asakawa, A. Inui, H. Yuzuriha, N. Ueno, G. Katsuura, M. Fujimiya, et al.
Characterization of the effects of pancreatic polypeptide in the regulation of energy balance.
Gastroenterology, 124 (2003), pp. 1325-1336
[20.]
J. Berger, D.E. Moller.
The mechanisms of action of PPARs.
Annu Rev Med, 53 (2002), pp. 409-435
[21.]
Y.X. Wang, C.H. Lee, S. Tiep, R.T. Yu, J. Ham, H. Kang, et al.
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity.
Cell, 113 (2003), pp. 159-170
[22.]
A. Cederberg, L.M. Gronning, B. Ahren, K. Tasken, P. Carlsson, S. Enerback.
FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance.
Cell, 106 (2001), pp. 563-573
[23.]
F. Picard, M. Gehin, J. Annicotte, S. Rocchi, M.F. Champy, B.W. OšfMalley, et al.
SRC-1 and TIF2 control energy balance between white and brown adipose tissues.
Cell, 111 (2002), pp. 931-941
[24.]
P. Puigserver, B.M. Spiegelman.
Peroxisome Proliferator-activated receptor-gamma coactivator 1a (PGC-1¿): transcriptional coactivator and metabolic regulator.
Endocr Rev, 24 (2003), pp. 78-90
[25.]
W.T. Garvey.
The role of uncoupling protein 3 in human physiology.
J Clin Invest, 111 (2003), pp. 438-441
[26.]
E. Nisoli, E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, C. Sciorati, et al.
Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.
Science, 299 (2003), pp. 896-899
[27.]
J. Hirosumi, G. Tuncman, L. Chang, C.Z. Gorgun, K.T. Uysal, K. Maeda, et al.
A central role for JNK in obesity and insulin resistance.
Nature, 420 (2002), pp. 333-336
[28.]
P. Cohen, C. Zhao, X. Cai, J.M. Montez, S.C. Rohani, P. Feinstein, et al.
Selective deletion of leptin receptor in neurons leads to obesity.
J Clin Invest, 108 (2001), pp. 1113-1121
[29.]
T. Kitamura, C.R. Kahn, D. Accili.
Insulin receptor knockout mice.
Annu Rev Physiol, 65 (2003), pp. 313-332
[30.]
N. Yahagi, H. Shimano, A.H. Hasty, T. Matsuzaka, T. Ide, T. Yoshikawa, et al.
Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers, but not obesity or insulin resistance in Lepob/Lepob mice.
J Biol Chem, 277 (2002), pp. 19353-19357
[31.]
E.S. Bachman, H. Dhillon, C.Y. Zhang, S. Cinti, A.C. Bianco, B.K. Kobilka, et al.
βAR signaling required for diet-induced thermogenesis and obesity resistance.
Science, 297 (2002), pp. 843-845
[32.]
P. Cohen, M. Miyazaki, N.D. Socci, A. Hagge-Greenberg, W. Liedtke, A.A. Soukas, et al.
Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.
Science, 297 (2002), pp. 240-243
[33.]
E.E. Schadt, S.A. Monks, T.A. Drake, A.J. Lusis, N. Che, V. Colinayo, et al.
Genetics of gene expression surveyed in maize, mouse and man.
Nature, 422 (2003), pp. 297-302
[34.]
D.E. Cummings, M.W. Schwartz.
Genetics and pathophysiology of human obesity.
Annu Rev Med, 54 (2003), pp. 453-471
[35.]
I.S. Farooqi, J.M. Keogh, G.S. Yeo, E.J. Lank, T. Cheetham, S. Ošf-Rahilly.
Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.
N Engl J Med, 348 (2003), pp. 1085-1095
[36.]
J. Korner, L.J. Aronne.
The emerging science of body weight regulation and its impact on obesity treatment.
J Clin Invest, 111 (2003), pp. 565-570
Copyright © 2004. Sociedad Española de Endocrinología y Nutrición